Filing Flows › Idexx Laboratories (IDXX) › Q2 2026 › vs Q2 2025
Idexx Laboratories (IDXX) Q2 2026 vs Q2 2025 (year over year)
Idexx Laboratories's revenue rose $107M (+10%) from $1.1B in Q2 2025 to $1.2B in Q2 2026. The biggest changes: Product revenue +$61.1M (+9%); Service revenue +$46.1M (+10%). Gross margin 64.0% against 62.6% (+1.4 pts).
Idexx Laboratories, Q2 2026: revenue $1.2B (+10% year over year), operating margin 35.0%, net earnings $338M, operating cash flow $347M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 64.0% | 62.6% | +1.4 pts |
| Operating margin | 35.0% | 33.6% | +1.4 pts |
| Net margin | 27.8% | 26.5% | +1.3 pts |
| Free cash flow margin | 26.5% | 13.7% | +12.8 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product revenue | $719M | $658M | $61.1M | +9% |
| Service revenue | $498M | $452M | $46.1M | +10% |
| Revenue | $1.2B | $1.1B | $107M | +10% |
| Gross profit | $779M | $695M | $84.4M | +12% |
| Cost of revenue | $437M | $415M | $22.8M | +5% |
| Operating profit | $426M | $373M | $52.5M | +14% |
| Operating expenses | $354M | $322M | $31.8M | +10% |
| Pre-tax earnings | $417M | $362M | $54.9M | +15% |
| Other expense, net | $8.3M | $10.7M | −$2.4M | -22% |
| Research & development | $65.4M | $61.9M | $3.5M | +6% |
| Sales & marketing | $171M | $161M | $10.2M | +6% |
| General & admin | $117M | $98.7M | $18.1M | +18% |
| Net earnings | $338M | $294M | $44.4M | +15% |
| Income tax | $78.8M | $68.4M | $10.4M | +15% |
| Depreciation & amortization | $41.1M | $35.8M | $5.3M | +15% |
| Share-based compensation | $16.1M | $14.9M | $1.2M | +8% |
| Working capital & other | $48.4M | $159M | −$110M | -70% |
| Operating cash flow | $347M | $186M | $161M | +87% |
| Free cash flow (OCF − capex) | $323M | $152M | $171M | +113% |
| Capital expenditures | $24.6M | $34.1M | −$9.5M | -28% |
Questions
How much did Idexx Laboratories's revenue grow year over year in Q2 2026?
Idexx Laboratories's revenue rose $107M (+10%) from $1.1B in Q2 2025 to $1.2B in Q2 2026.
What drove Idexx Laboratories's revenue change in Q2 2026?
Product revenue +$61.1M (+9%); Service revenue +$46.1M (+10%).